Report for Q1 2026
Filed with SSE · · 13 pages · Chinese
Zhejiang Jianfeng Group Co. Ltd. on 6ix
Earlier from Zhejiang Jianfeng
- Announcement on Withdrawal of Drug Registration Application by the Subsidiary
- Announcement on Implementation Result of Shares Repurchase and Share Changes
- Notice on Convening the 2025 Annual General Meeting
- Announcement on Progress in Repurchasing Shares through Call Auction
- Announcement on Subsidiary Obtaining a Notice of Disapproval for the Drug Marketing Authorization Application
Later from Zhejiang Jianfeng
- Announcement on Subsidiary Obtaining Approval for Marketing of Chemical APIs
- Announcement on Resolutions of the 2025 Annual General Meeting
- Announcement on Resignation of Directors
- Announcement on Overdue Financial Assistance Provided by a Subsidiary
- Announcement on Obtaining Drug Registration Certificate by Subsidiary
Follow Zhejiang Jianfeng into a list and get an email when it puts out news.
Follow Zhejiang Jianfeng